Table 1 Baseline characteristics of subjects categorized by LVH and LV geometry

Age (year)

67.8 ± 13.6

67.6 ± 10.8

0.823

67.6 ± 13.4

68.3 ± 14.0

66.5 ± 10.4

68.5 ± 11.0

0.188

Male, n (%)

371 (71.3)

115 (36.7)

<0.001

243 (71.7)

128 (70.7)

47 (33.6)

68 (39.3)

<0.001

Hypertension, n (%)

237 (45.6)

192 (61.3)

<0.001

151 (44.5)

86 (47.5)

79 (56.4)

113 (65.3)

<0.001

ACEI/ARB use, n (%)

219 (42.1)

159 (50.8)

0.015

139 (41.0)

80 (44.2)

59 (42.1)

100 (57.8)

0.003

Smoking, n (%)

116 (22.3)

74 (23.6)

0.657

72 (21.2)

44 (24.3)

36 (25.7)

38 (22.0)

0.695

Duration of diabetes (year)

9.8 ± 8.1

11.4 ± 9.0

0.010

9.4 ± 7.8

10.6 ± 8.7

11.5 ± 9.4

11.3 ± 8.7

0.023

SBP (mmHg)

134.7 ± 19.5

140.7 ± 19.3

<0.001

134.3 ± 19.4

135.4 ± 19.6

141.4 ± 21.4

140.2 ± 17.5

<0.001

DBP (mmHg)

78.7 ± 10.9

80.3 ± 11.2

0.048

79.2 ± 10.4

77.7 ± 11.7

78.6 ± 11.2

81.6 ± 11.0

0.008

BMI (Kg/M²)

24.2 ± 3.3

24.7 ± 4.5

0.079

24.0 ± 3.0

24.4 ± 3.8

25.2 ± 4.1

24.3 ± 4.8

0.038

Obesity, n (%)

56 (10.8)

68 (21.7)

<0.001

33 (9.7)

23 (12.7)

38 (27.1)

30 (17.3)

<0.001

Laboratory

FPG (mmol/L)

7.85 ± 3.11

7.78 ± 3.21

0.785

7.97 ± 3.31

7.63 ± 2.67

7.37 ± 2.43

8.12 ± 3.70

0.369

lg HOMA-IR

0.56 ± 0.32

0.61 ± 0.34

0.069

0.56 ± 0.33

0.57 ± 0.30

0.58 ± 0.31

0.62 ± 0.36

0.166

HbA1c (%)

8.16 ± 1.89

8.08 ± 1.98

0.518

8.17 ± 1.95

8.16 ± 1.78

8.03 ± 1.97

8.12 ± 2.00

0.898

Albumin (g/L)

39.19 ± 4.70

37.66 ± 5.24

<0.001

39.31 ± 4.62

38.96 ± 4.86

37.14 ± 5.46

38.08 ± 5.03

<0.001

Uric acid (μmol/L)

335.63 ± 100.71

342.15 ± 104.57

0.373

332.59 ± 101.36

341.31 ± 99.52

345.48 ± 110.94

339.45 ± 99.37

0.589

Creatinine (μmol/L)

81.23 ± 22.28

84.10 ± 27.90

0.123

80.42 ± 21.41

82.77 ± 23.80

86.91 ± 30.03

81.82 ± 25.91

0.531

lg Alb/Cr (mg/g)

1.57 ± 0.70

1.94 ± 0.63

<0.001

1.49 ± 0.68

1.72 ± 0.73

1.99 ± 0.62

1.90 ± 0.63

<0.001

Micro-albuminuria, n (%)

246 (47.3)

230 (73.5)

< 0.001

147 (43.4)

99 (54.7)

103 (73.6)

127 (73.4)

< 0.001

TG (mmol/L)

1.76 ± 1.11

1.95 ± 1.30

0.026

1.79 ± 1.21

1.71 ± 0.89

1.90 ± 1.43

1.99 ± 1.18

0.113

TC (mmol/L)

4.75 ± 1.18

4.91 ± 1.13

0.065

4.69 ± 1.19

4.87 ± 1.15

4.96 ± 1.15

4.87 ± 1.12

0.093

HDL-C (mmol/L)

1.11 ± 0.30

1.11 ± 0.46

0.781

1.11 ± 0.29

1.12 ± 0.31

1.14 ± 0.59

1.08 ± 0.32

0.301

LDL-C (mmol/L)

2.70 ± 0.86

2.77 ± 0.83

0.221

2.67 ± 0.87

2.76 ± 0.83

2.80 ± 0.79

2.75 ± 0.86

0.35

Dyslipidemia, n (%)

264 (50.8)

184 (58.8)

0.025

171 (50.4)

93 (51.4)

77 (55.0)

107 (61.8)

0.088

albumin-adjusted-Calcium (mg/dL)

8.93 ± 0.35

9.09 ± 0.40

< 0.001

8.92 ± 0.36

8.96 ± 0.32

9.04 ± 0.41

9.13 ± 0.39

< 0.001

Phosphate (mg/dL)

3.54 ± 0.47

3.57 ± 0.44

0.420

3.52 ± 0.46

3.58 ± 0.48

3.58 ± 0.43

3.56 ± 0.45

0.503

Calcium-Phosphate product (mg/dL)

31.69 ± 4.64

32.44 ± 4.16

0.016

31.46 ± 4.55

32.11 ± 4.79

32.33 ± 4.07

32.52 ± 4.23

0.007